Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
Will Penn State's enhanced NK cells enter human trials for solid tumors by end of 2025?  | Binary | 4 | 2 months ago | ||
Will dendritic cell transformation method be used in clinical trials by end of 2025? | Binary | 2 | 2 months ago | ||
Will Wyss Institute's metabolic labeling technology be tested in clinical trials by end of 2025? | Binary | 2 | 2 months ago | ||
What will be the first commercial application of NK cell enhancement by end of 2026? | Categorical | 2 | 2 months ago | ||
What will be the outcome of initial trials using dendritic cell transformation by end of 2026? | Categorical | 2 | 2 months ago | ||
What will be the adoption level of Wyss Institute's metabolic labeling technology by end of 2026? | Categorical | 2 | 2 months ago |